Portal de Periódicos da CAPES

The ubiquitin–proteasome system and its potential application in hepatocellular carcinoma therapy

2015; Elsevier BV; Volume: 379; Issue: 2 Linguagem: Inglês

10.1016/j.canlet.2015.06.023

1872-7980

Yanjie Chen, Hao Wu, Xizhong Shen,

Protein Degradation and Inhibitors

The ubiquitin-proteasome system (UPS) is a complicated tightly controlled system in charge of degrading 80-90% of proteins, and is central to regulating cellular function and keeping protein homeostasis. Therefore, the components of UPS attract considerable attention as potential targets for hepatocellular carcinoma (HCC) therapy. The clinical success of bortezomib in multiple myeloma and mantle cell lymphoma patients has set the precedent for therapeutically targeting this pathway. This review will provide an overview of the UPS in HCC and the current status of therapeutic strategies.